SGLT2 INHIBITORS IN IGA NEPHROPATHY: REAL-WORLD CLINICAL PRACTICE

被引：0
|
作者：
Garcia Carro, Clara [1 ]
Aiffil Meneses, Arianne [1 ]
Lopez Martinez, Marina [2 ]
Velo, Mercedes [1 ]
Rodriguez-Moreno, Antolina [1 ]
Soler Romeo, Maria Jose [2 ]
Sanchez Fructuoso, Ana [1 ]
机构：
[1] San Carlos Univ Clin Hosp, Nephrol, Madrid, Spain
[2] Vall dHebron Univ Hosp, Nephrol, Barcelona, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5814
引用
收藏
页码：I397 / I398
页数：2
相关论文
共 50 条
  • [1] Renoprotective Effects of SGLT2 Inhibitors in Japanese Real-World Clinical Practice
    Tosaki, Takahiro
    Sato, Shiori Toga
    Kondo, Masaki
    Yamada, Yuichiro
    Inagaki, Akemi
    Tsunekawa, Shin
    Himeno, Tatsuhito
    Kato, Yoshiro
    Nakamura, Jiro
    Kamiya, Hideki
    [J]. DIABETES, 2019, 68
  • [2] SGLT2 INHIBITORS IN IGA NEPHROPATHY: REAL LIFE EXPERIENCE AT OUR CENTRE
    Carvalho, Renata
    Medeiros, Joana
    Pires, Olga
    Bastos, Jose Mario
    Ribeiro, Barbara
    Viana, Johanna Rodrigues
    Vaz, Raquel
    Melo Marques, Sofia Homem
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1152 - I1152
  • [3] SGLT2 inhibitors in clinical practice
    Ryden, Lars
    Norhammar, Anna
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (07): : 434 - 435
  • [4] Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice
    Antonio Nicolucci
    Riccardo Candido
    Domenico Cucinotta
    Giusi Graziano
    Alberto Rocca
    Maria C. Rossi
    Franco Tuccinardi
    Valeria Manicardi
    [J]. Advances in Therapy, 2019, 36 : 2895 - 2909
  • [5] Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice
    Nicolucci, Antonio
    Candido, Riccardo
    Cucinotta, Domenico
    Graziano, Giusi
    Rocca, Alberto
    Rossi, Maria C.
    Tuccinardi, Franco
    Manicardi, Valeria
    [J]. ADVANCES IN THERAPY, 2019, 36 (10) : 2895 - 2909
  • [6] Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
    Dong, Yaping
    Shi, Sufang
    Liu, Lijun
    Zhou, Xujie
    Lv, Jicheng
    Zhang, Hong
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [7] A real-world study on SGLT2 inhibitors and diabetic kidney disease progression
    Liu, Allen Yan Lun
    Low, Serena
    Yeoh, Ester
    Lim, Eng Kuang
    Renaud, Claude Jeffrey
    Teoh, Selene Tse Yen
    Tan, Grace Feng Ling
    Chai, Chung Cheen
    Liu, Bo
    Subramaniam, Tavintharan
    Sum, Chee Fang
    Lim, Su Chi
    [J]. CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1403 - 1414
  • [8] SGLT2 inhibitors and kidney outcomes in the real world
    Smith, Steven M.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [9] Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
    Lopez-Martinez, Marina
    Torres, Irina
    Bermejo, Sheila
    Moreso, Francesc
    Garcia-Carro, Clara
    Vergara, Ander
    Ramos, Natalia
    Perello, Manel
    Gabaldon, Alejandra
    Azancot, M. Antonieta
    Bolufer, Monica
    Toapanta, Nestor
    Bestard, Oriol
    Agraz-Pamplona, Irene
    Soler, Maria Jose
    [J]. TRANSPLANT INTERNATIONAL, 2022, 35
  • [10] SGLT2 inhibitors in diabetic nephropathy Mechanisms and clinical effects
    Dumann, E.
    Haller, H.
    Menne, J.
    [J]. NEPHROLOGE, 2020, 15 (03): : 153 - 162
12345